Seeking Alpha

Galena Biopharma (GALE) files a registration statement (S-3) with the SEC to sell up to 9.47M...

Galena Biopharma (GALE) files a registration statement (S-3) with the SEC to sell up to 9.47M shares of its common stock on behalf of shareholders. If completed in full, the offering represents 18.8% of all outstanding shares.
Comments (3)
  • Broader
    , contributor
    Comment (1) | Send Message
     
    Individual investor with 15 year's experience in the market: I still can't tell the future.

     

    Are these treasury shares that Galena proposes to share?
    12 Apr 2012, 07:30 AM Reply Like
  • Christopher Wallace
    , contributor
    Comments (1060) | Send Message
     
    No, this is a registration of the intention of insiders to sell shares which they presently own.
    12 Apr 2012, 02:02 PM Reply Like
  • Ron Reed
    , contributor
    Comments (283) | Send Message
     
    Capital building for PHIII testing.
    14 May 2012, 10:27 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|